Resources

We established an Implementation Advisory Group to develop a roadmap for sequencing the government’s response to the recommendations. This document contains MSAC chair's response to the Minister regarding the final report of the HTA Review and provided their initial advice and reflections.

We established an Implementation Advisory Group to develop a roadmap for sequencing the government’s response to the recommendations. This document contains PBAC chair's response to the Minister regarding the final report of the HTA Review and provided their initial advice and reflections.

This document is the final report from the Health Technology Assessment Policy and Methods Review.

This document summarises the recommendations from the Health Technology Assessment Policy and Methods Review report.

This document outlines all of the recommendations from the Health Technology Assessment Policy and Methods Review final report.

The Enhanced Consumer Engagement Process was developed to provide recommendations on how to increase patient and consumer evidence and input earlier in the Health Technology Assessment (HTA) process. This report explains the recommendations developed by the Co-Design Working Group.

These guidelines contain the requirements to access support from the Extraordinary Assistance Fund (EAF) and Health Care Assistance Fund (HCAF) under the Australian Thalidomide Survivors Support Program.

This consultation document describes the proposed recommendations for the co-design of an Enhanced Consumer Engagement Process related to health technology assessment (HTA). Read this first to inform your responses to the consultation.

This document includes the consultation questions for the co-design of an Enhanced Consumer Engagement Process project’s consultation survey. View the consultation questions to help you prepare for your responses  to the online survey.

The National Site of Recognition was dedicated by the Minister for Health and Aged Care, along with thalidomide survivors and their families, on 30 November 2023. This is the program booklet from the ceremony.

This fact sheet is designed to help facilitate discussions between thalidomide survivors and their health care practitioners.

This communique outlines the main points from discussion from the National Site of Recognition Steering Committee meeting including the next steps in the development of the National Site of Recognition for thalidomide survivors and their families.

Details of the meeting of the National Site of Recognition for thalidomide survivors and their families Steering Committee held on 1 November 2021.

This fact sheet provides information for participants of the Australian Thalidomide Survivors Support Program about the categories of goods and services which are eligible to be claimed under the Extraordinary Assistance Fund (EAF).

This form is a template for health practitioners to provide evidence to support an eligible thalidomide survivor (patient) to receive support from the Extraordinary Assistance Fund (EAF) or the Health Care Assistance Fund (HCAF).

This fact sheet provides information about how participants of the Australian Thalidomide Survivors Support Program can make a claim to the Extraordinary Assistance Fund (EAF). The EAF helps cover the costs of goods and services to assist with activities of daily living.

This fact sheet provides information about how participants of the Australian Thalidomide Survivors Support Program can make a claim to the Health Care Assistance Fund (HCAF). The HCAF helps cover out-of-pocket health care expenses incurred as a direct result of thalidomide injuries.

This fact sheet provides information for participants of the Australian Thalidomide Survivors Support Program about the categories of goods and services which are eligible to be claimed under the Health Care Assistance Fund (HCAF).